|
Market Closed -
Nasdaq
01:30:00 22/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 286.29 USD | -0.38% |
|
-2.82% | +51.42% |
| 07/08 | RBC Adjusts PT on Ligand Pharmaceuticals to $345 From $340, Maintains Outperform Rating | MT |
| 07/08 | Ligand Pharmaceuticals Incorporated, Q2 2026 Earnings Call, Aug 06, 2026 |
| Market Cap | 570.74Cr 488.89Cr 457.45Cr 418.74Cr 785.85Cr 55TCr 796.23Cr 5.4TCr 2.11TCr 27TCr 2.14TCr 2.1TCr 91TCr | P/E 2026 * |
54.7x | P/E 2027 * | 33.5x |
|---|---|---|---|---|---|
| Enterprise Value | 570.74Cr 488.89Cr 457.45Cr 418.74Cr 785.85Cr 55TCr 796.23Cr 5.4TCr 2.11TCr 27TCr 2.14TCr 2.1TCr 91TCr | EV / Sales 2026 * |
19.7x | EV / Sales 2027 * | 15x |
| Free-Float |
97.62% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Ligand Pharmaceuticals Incorporated
| 1 day | -0.38% | ||
| 1 week | -2.82% | ||
| Current month | -0.43% | ||
| 1 month | -5.91% | ||
| 3 months | +24.84% | ||
| 6 months | +55.61% | ||
| Current year | +51.42% |
| 1 week | 282.25 |  | 298.29 |
| 1 month | 282.25 | | 317.49 |
| Current year | 175.89 | | 326.63 |
| 1 year | 157.52 | | 326.63 |
| 3 years | 49.24 | | 326.63 |
| 5 years | 49.24 | | 326.63 |
| 10 years | 49.24 | | 326.63 |
| Manager | Title | Age | Since |
|---|---|---|---|
Todd Davis
CEO | Chief Executive Officer | 65 | 05/12/2022 |
Melanie Herman
DFI | Director of Finance/CFO | 47 | 21/05/2015 |
Octavio Espinoza
DFI | Director of Finance/CFO | 56 | 01/11/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
John Kozarich
CHM | Chairman | 76 | 01/03/2003 |
Jason Aryeh
BRD | Director/Board Member | 57 | 27/09/2006 |
Todd Davis
BRD | Director/Board Member | 65 | 01/03/2007 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/08/26 | Fiscal year | Chief Financial Officer | 94,923 | 0.4736% | ||
| 12/08/26 | Fiscal year | Director | 19,414 | 0.0969% | ||
| 03/08/26 | Fiscal year | General Counsel | 15,000 | 0.0748% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.38% | -2.82% | +79.97% | +331.16% | 570.74Cr | |
| +0.88% | +6.38% | +76.40% | +126.75% | 1,11900Cr | |
| +1.07% | +3.80% | +50.73% | +62.78% | 65TCr | |
| +1.20% | +6.21% | +25.81% | +78.74% | 47TCr | |
| +1.02% | +5.77% | +43.63% | +48.43% | 37TCr | |
| +0.85% | +4.07% | +24.97% | +40.58% | 30TCr | |
| +1.26% | +6.81% | +2.27% | +14.41% | 26TCr | |
| +1.88% | +5.81% | +49.57% | +70.53% | 24TCr | |
| +1.59% | +2.09% | -17.33% | -52.62% | 21TCr | |
| +1.87% | +5.61% | +27.32% | +91.38% | 18TCr | |
| Average | +1.12% | +4.20% | +36.33% | +81.21% | 38.06TCr | |
| Weighted average by Cap. | +1.14% | +5.08% | +44.31% | +73.04% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 29Cr 25Cr 23Cr 21Cr 40Cr 2.77TCr 40Cr 274.45Cr 107.03Cr 1.39TCr 108.83Cr 106.46Cr 4.61TCr | 38Cr 33Cr 30Cr 28Cr 52Cr 3.64TCr 53Cr 360.32Cr 140.51Cr 1.83TCr 142.87Cr 139.77Cr 6.05TCr |
| Net income | 11Cr 9.58Cr 8.96Cr 8.21Cr 15Cr 1.07TCr 16Cr 105.91Cr 41Cr 537.58Cr 42Cr 41Cr 1.78TCr | 19Cr 16Cr 15Cr 14Cr 26Cr 1.79TCr 26Cr 176.98Cr 69Cr 898.31Cr 70Cr 69Cr 2.97TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/26/21 | $286.29 | -0.38% | 1,52,536 |
| 20/26/20 | $287.39 | -1.14% | 1,38,945 |
| 19/26/19 | $290.71 | +1.08% | 2,31,199 |
| 18/26/18 | $287.59 | -1.43% | 2,47,480 |
| 17/26/17 | $291.77 | -0.96% | 1,45,603 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LGND Stock
Select your edition
All financial news and data tailored to specific country editions
